Sorry, this entry is only available in German!
GSK: FDA-Beratergremium empfiehlt die Zulassung von Mepolizumab für die Behandlung des schweren Asthma bronchiale bei Erwachsenen
The sender takes full responsibility for the content of this news item. Content may include forward-looking statements which, at the time they were made, were based on expectations of future events. Readers are cautioned not to rely on these forward-looking statements.
As a life sciences organization based in Vienna, would you like us to promote your news and events? If so, please send your contributions to news(at)lisavienna.at.